Handelsbanken Fonder’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,700
| Closed | -$247K | – | 1552 |
|
|
2025
Q1 | $247K | Hold |
34,700
| – | – | ﹤0.01% | 1457 |
|
|
2024
Q4 | $405K | Buy |
34,700
+2,300
| +7% | +$26.8K | ﹤0.01% | 1373 |
|
|
2024
Q3 | $666K | Buy |
32,400
+6,300
| +24% | +$130K | ﹤0.01% | 1118 |
|
|
2024
Q2 | $584K | Buy |
26,100
+7,100
| +37% | +$159K | ﹤0.01% | 1084 |
|
|
2024
Q1 | $523K | Hold |
19,000
| – | – | ﹤0.01% | 1145 |
|
|
2023
Q4 | $579K | Buy |
19,000
+5,400
| +40% | +$165K | ﹤0.01% | 1077 |
|
|
2023
Q3 | $430K | Hold |
13,600
| – | – | ﹤0.01% | 1117 |
|
|
2023
Q2 | $555K | Buy |
13,600
+2,800
| +26% | +$114K | ﹤0.01% | 1011 |
|
|
2023
Q1 | $403K | Hold |
10,800
| – | – | ﹤0.01% | 1112 |
|
|
2022
Q4 | $377K | Buy |
10,800
+1,300
| +14% | +$45.4K | ﹤0.01% | 1119 |
|
|
2022
Q3 | $532K | Hold |
9,500
| – | – | ﹤0.01% | 927 |
|
|
2022
Q2 | $492K | Hold |
9,500
| – | – | ﹤0.01% | 1028 |
|
|
2022
Q1 | $690K | Sell |
9,500
-1,900
| -17% | -$138K | ﹤0.01% | 982 |
|
|
2021
Q4 | $1.35M | Sell |
11,400
-2,600
| -19% | -$307K | 0.01% | 757 |
|
|
2021
Q3 | $1.88M | Buy |
+14,000
| New | +$1.88M | 0.01% | 636 |
|
|
2021
Q2 | – | Sell |
-10,300
| Closed | -$827K | – | 1722 |
|
|
2021
Q1 | $827K | Buy |
10,300
+500
| +5% | +$40.1K | ﹤0.01% | 930 |
|
|
2020
Q4 | $533K | Buy |
+9,800
| New | +$533K | ﹤0.01% | 1126 |
|